Potent ClpP agonists with anticancer properties bind with improved structural complementarity and alter the mitochondrial N-terminome-Reference-Cited by-同舟云学术

Potent ClpP agonists with anticancer properties bind with improved structural complementarity and alter the mitochondrial N-terminome

Published:2023-02 Issue:2 Volume:31 Page:185-200.e10
ISSN:0969-2126
Container-title:Structure
language:en
Short-container-title:Structure

Author:

Mabanglo Mark F.,Wong Keith S.,Barghash Marim M.,Leung Elisa,Chuang Stephanie H.W.,Ardalan Afshan,Majaesic Emily M.,Wong Cassandra J.,Zhang Shen,Lang Henk,Karanewsky Donald S.,Iwanowicz Andrew A.,Graves Lee M.,Iwanowicz Edwin J.,Gingras Anne-Claude,Houry Walid A.^ORCID

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference55 articles.

1. Protein quality control at the mitochondrion;Voos;Essays Biochem.,2016

2. Mitochondrial proteostasis in the context of cellular and organismal health and aging;Moehle;J. Biol. Chem.,2019

3. Substrates and interactors of the ClpP protease in the mitochondria;Mabanglo;Curr. Opin. Chem. Biol.,2022

4. Recent structural insights into the mechanism of ClpP protease regulation by AAA+ chaperones and small molecules;Mabanglo;J. Biol. Chem.,2022

5. Crystallography and mutagenesis point to an essential role for the N-terminus of human mitochondrial ClpP;Kang;J. Struct. Biol.,2004

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of novel imipridone derivatives with potent anti-cancer activities as human caseinolytic peptidase P (hClpP) activators;Bioorganic Chemistry;2024-12

2. Impact of a novel caseinolytic protease single mutation on Lactiplantibacillus pentosus growth performance;Process Biochemistry;2024-10

3. Structure-Based Design and Development of Phosphine Oxides as a Novel Chemotype for Antibiotics that Dysregulate Bacterial ClpP Proteases;Journal of Medicinal Chemistry;2024-09-02

4. Combining the constitutive TRAIL-secreting induced neural stem cell therapy with the novel anti-cancer drug TR-107 in glioblastoma;Molecular Therapy: Oncology;2024-09

5. Discovery of Dehydrogenated Imipridone Derivatives as Activators of Human Caseinolytic Protease P;Journal of Medicinal Chemistry;2024-08-22